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Mouse embryonic ﬁbroblasts (MEFs) and human foreskin ﬁbroblasts (hFFs) are commonly used as feeder cells to maintain the
pluripotent state of stem cells. The aim of the present study was to evaluate the eﬀect of MEF and hFF feeders on the cardiac
diﬀerentiation. Two human embryonic and two induced pluripotent stem cell lines were cultured on MEF and hFF before cardiac
diﬀerentiation. The expression of Brachyury T was higher in cell lines cultured on MEF, than if cultured on hFF, suggesting
enhanced mesoderm formation. However, signiﬁcant positive inﬂuence of MEF feeders on cardiac diﬀerentiation was only seen
with one cell line. Further, the ability of hFF to maintain pluripotency of stem cells originally cultured on MEF was quite poor.
In conclusion, the cells behaved diﬀerently whether cultured on hFF or MEF feeders. However, the inﬂuence of the feeder cells on
diﬀerentiation was less than the diﬀerence observed between the cell lines.
1.Introduction
Theﬁrsthumanembryonicstemcell(hESC)linewasderived
in 1998 [1]. Currently, pluripotent stem cells can also be
obtained from human somatic cells by reprogramming the
c e l l sw i t had e ﬁ n e ds e to ff a c t o r s[ 2, 3]. hESCs and induced
pluripotent stem (iPS) cells require complex culture systems
comprising of specialized media and mouse or human
feeder cell layers that support the undiﬀerentiated state and
pluripotency [1, 4, 5]. Several feeder cell-free culture systems
using extracellular matrix (ECM) components instead of
feeder cell layers have also been developed [6–9].
Feeder cells support the growth of pluripotent stem
cells by producing growth factors and providing adhesion
molecules and ECM components for cell attachment. hESCs
were originally derived and cultured on mouse embryonic
ﬁbroblast (MEF) feeder cell layers [1]. To overcome the
problem of xenocontamination, feeder cells have also been
d e r i v e df r o ms e v e r a lh u m a nc e l lt y p e s ,s u c ha sh u m a n
foreskin ﬁbroblasts (hFFs) or adult Fallopian tube epithelial
cells [4, 10–14]. However, the ability of diﬀerent types of
human feeder cells to support the undiﬀerentiated growth
o fh E S C sv a r i e s[ 11, 15]. Activin A and basic ﬁbroblast
growth factor (bFGF) are key factors in maintenance the
pluripotent state of stem cells [15, 16]. Mouse feeder cells
express more Activin A than human feeder cells, but they
do not express bFGF like human feeder cells [15]. When
compared to human feeder cells, MEFs support better the
undiﬀerentiated growth of some hESC lines, whereas more
spontaneousdiﬀerentiationandalowerproportionofSSEA3
positive cells can be observed with human feeder cells [15].
hESCs and iPS cells can be induced to diﬀerentiate
into cardiomyocytes by multiple methods [17–24]. We have
previously demonstrated that hESC lines diﬀer in their
cardiac diﬀerentiation potential [25], and all the cell lines
used in our earlier study had a relatively poor cardiac
diﬀerentiation eﬃciency. The H7 hESC line is widely used in
stem cell research, and it has been reported to have relatively
good cardiogenic potential in cardiac diﬀerentiation studies
[20, 26]. The major diﬀerence in the H7 cell line and hESC2 Stem Cells International
Table 1: Human pluripotent stem cell lines used in present study.
Stem cell line Original feeder type Adapted to Code for the line Passages used in diﬀerentiation
H7 MEF — H7 (MEF) 39–43 and 53
hFF H7 (hFF) 41–43 (cultured on hFF for 5–7 passages)
UTA.00106 MEF — UTA.00106 (MEF) 18–23
hFF UTA.00106 (hFF) 20–23 (cultured on hFF for 5–8 passages)
UTA.00112 MEF — UTA.00112 (MEF) 44-45 and 63
hFF UTA.00112 (hFF) 55–57 (cultured on hFF for 7–9 passages)
Regea 08/017 hFF — Regea 08/017 (hFF) 32–34
MEF Regea 08/017 (MEF) 31–36 (cultured on MEF for 5–9
passages)
lines derived in our institute is that we have used human
feeder cells, while H7 has been derived and cultured MEFs.
Therefore, we hypothesized that the feeder cell type aﬀects
cardiac diﬀerentiation eﬃciency. To evaluate the eﬀect of
feeder cells on cardiac diﬀerentiation, we adapted our hESC
line, Regea 08/017, to MEFs and H7 to hFF feeder cells. In
addition, we compared the diﬀerentiation of two human iPS
cell lines UTA.00106 and UTA.00112 on both feeder types.
2.MaterialsandMethods
2.1. Cell Culture. The hESC lines Regea 08/017 [27]a n d
H7 (WiCell Research Institute) and the human iPS cell
lines UTA.00106 and UTA.00112 (derived at the Institute
of Biomedical technology, IBT, University of Tampere) were
used. The study was conducted in accordance with the
Ethics Committee of Pirkanmaa Hospital District to derivate
and culture hESC and iPS cell lines. The iPS cell lines
were induced from hFF (American Type Culture Collection,
Manassas,VA)byretroviraltransfectionofOct4,Sox-2,Klf4,
and c-Myc [28].
2.1.1. Adaptation. H7, UTA.00106 and UTA.00112 cell lines
were normally cultured on MEFs (Millipore) and adapted to
hFF (American Type Culture Collection) feeder cells for at
least5passages.Regea08/017celllinewasculturedoriginally
on hFF feeder cells as previously described [27]a n da d a p t e d
to MEF feeder cells for at least 5 passages. The cell lines and
adaptation procedure are presented in Table 1.
The hESC culture medium (KSR) comprised of knock-
out DMEM (Invitrogen, Carlsbad, CA, USA) containing
20% knockout serum replacement (KO-SR; Invitrogen),
1% nonessential amino acids (Cambrex Inc., Walkersville,
MD, USA), 2mM GlutaMax (Invitrogen), 50U/mL peni-
cillin/streptomycin (Cambrex), 0.1mM 2-mercaptoethanol
(Invitrogen), and 8ng/mL bFGF (R&D Systems, Minneapo-
lis, MN, USA). The undiﬀerentiated state of the colonies was
conﬁrmed daily by morphologic analysis and with periodic
testing for the expression of the stem cell markers Nanog,
Oct4, SSEA4, and TRA-1-60. In addition, stem cell lines were
also analyzed for their karyotypes which were all normal for
lines H7, Regea 08/017, and UTA.00112, whereas UTA.00106
had an inversion in chromosome 12 (46, XY inv(12)).
2.2.DiﬀerentiationofCardiomyocytes. Cardiomyocytediﬀer-
entiationwasinducedbycoculturinghESCandiPScellswith
END-2 cells. END-2 cells were cultured as described earlier
[29]. The passages used in diﬀerentiation experiments are
described in Table 1. To initiate diﬀerentiation, undiﬀeren-
tiated cell colonies were dissected mechanically. The whole
MEF feeder cell layer was removed carefully with pipette tip
from the stem cell cultures and the undiﬀerentiated colonies
were detached by scraping with a cell scraper. The hFF
feeder cell layer could not be removed using this method and
thereforethestemcellcoloniesweredetachedfromthefeeder
cell layer using a scalpel. Pieces of cell colonies containing
a few hundred cells were placed on top of plated END-2
cells (30pieces/well) in KSR culture medium with 3mg/mL
ascorbic acid and without serum, KO-SR, or bFGF [19]. The
medium was changed after 5, 8, and 12 days of culturing.
After 16 days, 10% KO-SR was added to the medium.
2.2.1. Estimation of the Diﬀerentiation Eﬃciency. The diﬀer-
entiationeﬃciencywascalculatedbycountingthenumberof
beatingareasandbycytospinanalysisatday21.Beatingareas
were counted from at least 24 wells of 12-well plates. For
cytospin analysis, the cells from three wells of a 12-well plate
(wells A1, B1, and C1) were trypsinized (20min at +37◦C).
The total number of cells was determined and 5 × 105 cells
resuspended in a total volume of 12mL PBS. The cells were
spun at 800rpm for 5min onto polysine slides (Thermo
Scientiﬁc) by the cytospin system (Cyto-Tech, Sakura). Cells
were ﬁxed with 4% paraformaldehyde (Sigma-Aldrich) and
stained by anti-troponin T (Abcam). The percentage of
troponin T-positive cells versus the total cell number (40,
6-diamidino-2-phenylindole [DAPI] staining of nuclei) was
determined by counting at least 1500 cells (3 × 500 cells).
Counted ﬁelds were randomly selected in the DAPI channel
and under by using 20x magniﬁcation.
2.3. Immunocytochemistry
2.3.1. Characterization of Undiﬀerentiated Colonies. hESC
and iPS cell colonies were ﬁxed in 4% paraformaldehyde
and stained with primary antibodies Oct4 (1:400, R&D
Systems), Nanog (1:200, R&D Systems), TRA-1-60 (1:200,
Millipore), and SSEA4 (1:200, Santa Cruz Biotechnology).
Alexa Fluor 568 and 488-conjugated donkey anti-goat andStem Cells International 3
anti-mouse antibodies were used as secondary antibodies
(1:800, Invitrogen). Cells were mounted with Vectashield
(Vector Laboratories) containing DAPI for staining nuclei.
2.3.2. Characterization of Beating Cells. Beating areas were
dissociated from cocultures 21 days after plating as pre-
viously described [25]. Immunocytochemical staining was
performed with primary antibodies anticardiac troponin
T (1:500, Abcam), antiventricular α-myosin heavy chain
(αMHC)(1:50, Chemicon), andanti-Connexin 43(1:1500,
Chemicon).
2.4. Assessment of the Germ Layer Markers by Quantitative
RT-PCR. Quantitative RT-PCR was performed according
to the standard protocols on Abi Prism 7300 instrument
(Applied Biosystems, Foster City, CA, USA). All cells from
two END-2 coculture wells were collected and pooled at
0, 3, 6, and 12 days after initiating coculture. Total RNA
was isolated with a NucleoSpin RNA II kit including DNAse
treatment (Machery-Nagel, Duren, Germany). The concen-
trationandqualityofRNAweremonitoredspectroscopically
(Nanodrop, Wilmington, DE, USA) and 1μgo ft o t a lR N A
was transcribed to cDNA in a total volume of 20μLw i t h
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). The PCR reaction comprised of 0.3μL cDNA,
7.5μL of 2x PCR Mastermix (Applied Biosystems), and
300nM of each primer. Primer sequences were described
previously[25].Inaddition,theexpressionofOct4(POU5F)
was determined by using the same cDNA, but the detection
was performed by using the primer-probe sets NM 053275.3
for RPLP0 (endogenous control) and Hs00999632 g1 for
POU5F (Oct4; Applied Biosystems).
Cτ values were determined for every reaction and the rel-
ative quantiﬁcation was calculated with the 2−ΔΔCτ method
[30]. The data were normalized to the expression of the
endogenouscontrol(RPLP0).The0-dayMEFsampleofeach
cell line was used as the calibrator for diﬀerentiation studies
and H7 (MEF) 0 d p43 sample for undiﬀerentiated state
analysis. Two biological replicates from each cell line were
analyzed in triplicate. Results are shown as the mean values
of both biological replicates.
2.5. Statistical Analysis. Quantitative RT-PCR data is pre-
sented as mean values +/− standard deviation. Statistical
signiﬁcance for qPCR data was determined by using Mann-
Whitneytest,andt-testwasusedfordiﬀerentiationeﬃciency
data. Diﬀerence was considered to be statistically signiﬁcant
with the P value of <0.05.
3. Results
3.1. Culture Adaptation. hESC line H7 and human Ips cell
lines UTA.00106 and UTA.00112 were initially derived and
maintained on MEF feeder cells and adapted to grow on
hFF feeder cells for at least ﬁve passages. On the contrary,
Regea 08/017 was established and originally cultured on
hFF feeder cells and, therefore, adapted onto MEF for at
least ﬁve passages as presented in Table 1. Regea 08/017 cells
are usually passaged manually. However, to establish more
similar culture conditions for the cell lines in the present
study, these cells were also passaged enzymatically on hFF
feeder cells.
Regea 08/017 cells grew well on MEF feeder cells with
enzymatic passaging and the morphology of the colonies
resembled H7, UTA.00106 and UTA.00112. Adaptation from
MEF to hFF feeder cells, however, was more problematic.
Overall,cellsgrewwellandformedpropercoloniesbutbased
onthevisualinspection,thecellsweremorediﬀerentiatedon
hFFthanonMEFfeedercells(datanotshown).Comparedto
manual passaging, enzymatic passaging gives rise to greater
amount of cell colonies. The higher amount of colonies
mightalterthefeedercelllayertodetachfromthecellculture
well.ThisphenomenonwasobservedwithhFFfeedercellsin
the present study.
3.2. Assessment of the Ability of MEF and hFF to Main-
tain the Undiﬀerentiated State of Stem Cells. Based on the
immunocytochemistry of pluripotent markers, both feeder
cell layers supported the hESC and iPS cells to maintain their
pluripotent state (Figure 1). Performed qPCR studies also
supported immunocytochemistry results. Oct4 expression
was constant in all cell lines between passages and on both
feeder cells. Basal expression levels of germ layer markers
were also tested by qPCR. According to these results, Regea
08/017 had a low basal expression of Brachyury T, AFP, and
Sox-1 on both of the feeder cell types and at all passages
studied (Figure 2). However, increased germ layer marker
expression was observed in the H7 cell line cultured on
hFF compared to H7 cultured on MEFs (Figure 2). The
expression of Brachyury T, AFP, and Sox-1 increased during
culture of H7 on hFFs between passages p43 (7 passages on
hFFfeeders)andp48(12passagesonhFFfeeders)(P<0.05).
The expression of Brachyury T, AFP and SOX-1 was also
signiﬁcantly higher in H7 cells on hFF feeders than in H7
cultured on MEF feeders (P<0.05).
The gene expression levels of germ layer markers in
the iPS cell lines UTA.00106 and UTA.00112 were quite
variable. Increase in germ layer marker expression levels was
more obvious in hFF cultures but especially for UTA.00112
expression levels of Brachyury T, AFP, and Sox-1 ﬂuctuated
at the undiﬀerentiated state on both of the feeder cell types
(Figure 2).
3.3. Assessment of Germ Layer Markers during Cardiac
Diﬀerentiation. Oct4 expression decreased rapidly during
diﬀerentiation (Figures 3(a)–3(d)), reaching a constant low
level after day 6 in all the cell lines studied (P<0.05).
Oct4expressiondecreasedmoreslowlyinRegea08/017(hFF)
compared to H7 (MEF) and H7 (hFF) and UTA.00106 (hFF)
at day 3 (P<0.05), and the diﬀerences were still signiﬁcant
on day 6 when compared to H7 (MEF) (P<0.05).
Mesodermal marker Brachyury T expression
(Figure 3(e)) was signiﬁcantly higher at day 3 on H7 cul-
tur edonMEFthanH7cultur edonhFF(P<0.01).Similarly,
BrachyuryTexpressionwashigherforRegea08/017cultured
on MEFs than for Regea 08/017 cultured on hFFs (P<0.01)4 Stem Cells International
(a) (b)
200 µm
(c)
200 µm
(d)
200 µm
(e)
200 µm
(f)
200 µm
(g)
200 µm
(h)
200 µm
(i)
200 µm
(j)
200 µm
(k)
200 µm
(l)
200 µm
(m)
200 µm
(n)
200 µm
(o)
200 µm
(p)
Figure 1: Undiﬀerentiated H7 hESC colonies (on passage 15) 3 days after passaging on hFF feeder cells (a) and after 55 passages on MEF
feeder cells (b). H7 cells passaged 11 times on hFF feeder cells expressed Nanog (c and d), Oct4 (e and f), SSEA4 (g and h), and TRA-1-60 (i
and j). H7 cells on passage 45 on MEF feeder cells expressed Nanog (k and l), Oct4 (m and n), and SSEA4 (o and p). Scale bars 200μm.
(Figure 3(f)). Brachyury T expression peaked later (at day
6) in H7 (hFF) than in H7 (MEF). Regea 08/017 (hFF)
had a similar expression curve having the expression peak
at day 6. Expression levels for UTA.00106 were similar for
both of the feeder cell types, peaking at day 3 (Figure 3(g)).
However the curve for UTA.00112 was broader. In addition,
for UTA.00112 on hFF culture, the level of Brachyury T
expression was elevated when compared to MEF cultures,
but the diﬀerence was already seen at day 0 (Figure 3(h)).
The expression curve for AFP was similarly shaped for
all cell lines studied, having modest increase before day 6
but increasing strongly after day 6 (data not shown). Sox-
1 expression trend was also similar in the cell lines, levels
increasing from day 3 to 12 (data not shown).
Signiﬁcant diﬀerence in Brachyury T expression level
and the peak in expression was observed when the qPCR
data from END-2 diﬀerentiation samples was analysed by
combining the cells cultured on MEF and cells cultured
on hFF (Figure 4(a)). In MEF cultures, the expression of
Brachyury T at day 3 is higher than in hFF cultures (P<
0.05), and the expression level also decreased signiﬁcantly
more by day 6 (P<0.05). Similar clear peaking at day 3 was
not observed in hFF cultures,and no diﬀerence between days
3 and 6 was observed in hFF cultures. On the contrary, the
level of Brachyury T was higher in hFF cultures at day 6 than
in MEF cultures (P<0.05).
3.4. Cardiac Diﬀerentiation Eﬃciency. The cardiac diﬀerenti-
ation rate was estimated by counting the number of beating
areas from at least 24 wells of 12-well plate. In addition, the
percentage of troponin T-positive cells was quantiﬁed using
the cytospin method. Both methods gave equivocal results,Stem Cells International 5
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Figure 2:RelativegeneexpressionlevelsoftheundiﬀerentiatedstemcelllinesonMEF(a)andonhFF(b).TheH7MEFp43samplehasbeen
used as the calibrator for all samples. Regea 08/017 has modest and steady expression levels of germ layer markers, whereas the expression
levels in the iPS cell lines vary between passages.
which are summarized in Figure 4(b). H7 and UTA.00112
cell lines had the best diﬀerentiation eﬃciency in this
study. The iPS cell line UTA.00106 had also a relatively
good, while Regea 08/017 had a poor, cardiac diﬀerentiation
eﬃciency. Adaptation to the hFF feeder cells decreased the
diﬀerentiation eﬃciency of H7 (from 3.38 to 0.67 beating
areas per well) and UTA.00106 (from 1.36 to 0.83 beating
areas per well) cell lines. A modest decrease in UTA.00112
wasalsoobserved(from3.83to3.5).Respectively,adaptation
to MEF feeder cells increased the diﬀerentiation rate of the
Regea 08/017 line (from 0.17 to 0.76 beating areas per well).
As mentioned earlier, to support the diﬀerentiation
eﬃciency determination, the number of troponin T-positive
cells was determined, by cytospin analysis. Even though a
similar amount of undiﬀerentiated cells was plated on END-
2 cells, after 21 days of coculturing, the total cell number
in each well varied notably between the cell lines. The
diﬀerences were also obvious by visual inspection. After 3
weeks of diﬀerentiation H7, UTA.00106, and UTA.00112
formed large cell structures, whereas the growth of Regea
08/017 was more restricted. This phenomenon was observed
withbothofthefeedercelltypes.Inaddition,cellgrowthwas
not aﬀected by feeder cell type. The total number of cells in
a well after 3 weeks in diﬀerentiation was the lowest in the
Regea 08/017 line on both feeder cell types. When this data
wascombinedwiththecytospinanalysis,theaveragenumber
of cardiomyocytes in a well was calculated (Figure 4(b)).
The amount of troponin T-positive cells was signiﬁcantly
higher for H7 (MEF) (36122 cells) than H7 (hFF) (14482
cells) (P<0.01). The diﬀerentiation eﬃciency determined
by the cytospin methods of iPS cell lines UTA.00106 and
UTA.00112didnotdiﬀerbetweentheMEFandhFFcultures.
For the hESC line Regea 08/017, the number of cells in total
and the number of troponin T-positive cells were notably
lower when compared to H7. In addition, in Regea 08/017
the amount of troponin T-positive cells was slightly but not
signiﬁcantly higher when cultured on MEFs (2226) than on
hFFs (1024) cultures (P = 0.087).
3.5. Immunocytochemistry. Beating cells from every cell line
used in the study were positively stained by cardiac troponin
T, and the staining revealed a striated pattern (Figures
4(c)–4(g)). In addition, Connexin 43 staining revealed gap
junction structures between the cells (Figures 4(f)-4(g)).
Most of the troponin T-positive cells were also positive
for ventricular α-MHC (Figures 4(d)-4(e)) revealing the
percentage of ventricular cells from the whole cardiomyocyte
population (Figure 4(b)). The percentage of ventricular
cardiomyocytes was independent of the feeder cell type.
Regea 08/017, H7, UTA.00106, and UTA.00112 formed a6 Stem Cells International
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Figure 3: Oct4 (a–d) and Brachyury T (e–h) expression levels of H7, Regea 08/017, UTA.00106, and UTA.00112 cell lines on MEF and hFF
feeder cells.Stem Cells International 7
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between hFF and MEF cultures on days 3 and 6 are statistically signiﬁcant. In addition, the diﬀerence in expression levels of Brachyury
T of MEF cultures between days 3 and 6 is statistically signiﬁcant. Table in (b): Diﬀerentiation data of H7, Regea 08/017, UTA.00106,
and UTA.00112 cell lines on MEF and hFF feeder cells. For H7, the diﬀerence between troponin T-positive cells is statistically signiﬁcant,
(P<0.01). (c–h) Characterization of the diﬀerentiated cells. Troponin T (c), ventricular α-myosin heavy chain (d), and merged image with
DAPI staining (e). Scale bar, 200 μm. (f) Merged image with Troponin T (red) and Connexin 43 (green) revealing gap junctions between
the cells. Scale bar 100 μm. (g) Inset of image (f). (h) Cytospin slide of H7 (MEF) stained by troponin T (red) and DAPI (blue). Scale bar,
100μm.8 Stem Cells International
mean of 68.5%, 58%, 79.5%, and 74.5% cardiomyocytes of
ventricular type, respectively.
4. Discussion
It has been demonstrated earlier that hESC lines diﬀer in
their cardiac diﬀerentiation potential [25]. However, the
cardiac diﬀerentiation eﬃciency for all the cell lines used in
that study was relatively poor. On the contrary, the hESC
line H7 is widely used in stem cell research and in cardiac
diﬀerentiation studies with a relatively good cardiogenic
potential [20, 26], and it also had the best diﬀerentiation
eﬃciency in the present study. The major diﬀerence in
the H7 cell line and hESC lines derived in our institute
is that we have used human feeder cells while H7 has
been initially derived and cultured on MEFs. Therefore,
we hypothesized that the feeder cell type has an eﬀect on
cardiac diﬀerentiation. To evaluate the eﬀect of feeder cells
on cardiac diﬀerentiation more thoroughly, we adapted one
of our hESC lines, Regea 08/017 to MEFs, and H7 cell line
to hFF feeder cells. In addition, we compared the cardiac
diﬀerentiation of two human iPS cell lines UTA.00106 and
UTA.00112 on both feeder types.
Cardiomyocyte diﬀerentiation can be predicted by the
transient expression of the early mesodermal marker Bra-
chyury T. Brachyury T expression peak is normally detected
at the time point of 3 days in END-2 cocultures [31].
Indeed, increased Brachyury T expression was seen when,
for example, hESC line Regea 08/017 was cultured on
MEF feeder cell layer compared to hFF feeders, indicating
the elevated mesodermal diﬀerentiation. In addition, the
number of beating areas for Regea 08/017 increased after
MEF adaptation but the diﬀerence in the number of
Troponin T positive cardiomyocytes did not reach statistical
signiﬁcance.However,theculturingofH7onhFFfeedercells
decreased the diﬀerentiation eﬃciency and also the num-
ber of troponin T-positive cells signiﬁcantly. In addition,
Brachyury T expression level was, respectively, decreased in
H7 (hFF) compared to H7(MEF). However, the number of
beating areas per well is a crude indication of diﬀerentiation
eﬃciency. A beating area may be formed by a few to several
thousands of cardiomyocytes [19]. Therefore, the cytospin
method in combination with immunocytochemistry was
used to support the diﬀerentiation eﬃciency data. Indeed,
for example, the number of Troponin T-positive cells for the
iPS cell line UTA.00112 was notably low if compared to the
number of beating areas. This might be explained by the size
of the beating areas and by the total number of cells in a well.
The diﬀerentiation eﬃciency of H7 cultured on MEFs
was the highest in our study, resulting in 3.38 beating areas
per well and on the average of 36122 cardiomyocytes. In
addition to H7 (MEF), the iPS cell lines UTA.00106 and
UTA.00112 cultured on MEFs had a relatively good diﬀer-
entiation rate with 1.36 beating areas (9021 cardiomyocytes)
and 3.83 beating areas (10641 cardiomyocytes) per well,
respectively. These numbers are similar to the previously
reported results of END-2 cocultures of the HES-2 line,
which formed a mean of 2.7 beating areas per well in serum-
free medium [19].
In general, the cardiac diﬀerentiation of the human iPS
cell lines UTA.00106 and UTA.00112 were similar to that of
hESClines;beatingareasoccurredonthesametimescaleand
were morphologically alike. This is consistent with previous
reports where iPS cells were diﬀerentiated to cardiomyocytes
using the END-2 and embryoid body methods [22–24]. For
iPS cell lines, the notable observation made in the present
studywasthatfeedercelltypedidnothaveasigniﬁcanteﬀect
on the cardiac diﬀerentiation eﬃciency.
One potential factor aﬀecting cardiac diﬀerentiation
eﬃciency might be Activin A. Activin A is essential for
undiﬀerentiated growth of hESC and is expressed more by
MEFs than hFFs [15]. In addition, it aﬀects the expression
of pluripotency genes such as Oct4 and Nanog [16]. The
enhanced Oct4 expression was not observed on hESC or
iPS cells maintained on MEF compared to hFF. However,
Activin A also induces the expression of growth factors such
as Nodal, Wnt3, bFGF, and FGF-8 [16]. In addition, it has
been used in combination with BMP-4, to induce cardiac
diﬀerentiation with the formation of a primitive streak-like
population and mesoderm [20, 21]. Based on the Brachyury
T expression, mesoderm formation was more eﬃcient in H7
and Regea 08/017 cell lines cultured on MEF than when cul-
tured on hFF.
In addition, when the MEF and hFF cultures were com-
pared,MEF-culturedcellshadelevatedBrachyuryexpression
levels on day 3 and had a clear expression peak at this time
point. As previously reported, Brachyury T expression peaks
at day 3 and the delayed expression is indicative of poor
cardiac diﬀerentiation [32]. Our results support this ﬁnding,
as the expression peak was sharper and occurred earlier for
MEF than hFF cultures, and the diﬀerentiation eﬃciency
seemed to be higher in the MEF cultures.
An o t a b l ed i ﬀerence between the cell lines studied was
on the rates of the cell proliferation. At the initiation of
coculturing, similar amounts of cells were plated on END-2
cells. However, after 21 days of coculturing, the total number
of cells in Regea 08/017 cocultures was much lower than the
number of cells in other cell lines thus resulting also smaller
cardiomyocyte number. Activin A might also have a role in
enhancing cell proliferation [33]. Therefore, the increased
l e v e lo fA c t i v i nAc o u l de x p l a i nb e t t e rc e l lp r o l i f e r a t i o no f
H7 and iPS cell lines which have been originally derived and
cultured on MEFs. In addition, the proliferative capability
might also be cell line-speciﬁc, because adaptation from hFF
to MEF did not have such an eﬀect to total cell number.
Regea 08/017 on MEF did not reach the proliferation level
of UTA.00106, UTA.00112 or H7. A similar phenomenon
was observed in our previous study, where diﬀerentiation
on embryoid bodies was monitored; the growth of embryoid
bodies varied between hESC lines [34].
Based on immunocytochemistry, both the MEF and
hFF feeder cells maintained the undiﬀerentiated growth
of pluripotent stem cells. From the germ layer marker
expression levels, however, it can be concluded that if
the line has been derived and maintained on hFF, hFF
feeder cells are able to maintain the pluripotent state and
preventdiﬀerentiation.Onthecontrary,whenH7,whichhas
originally been cultured on MEFs, was grown on hFF feederStem Cells International 9
cellsfor7to12passagestheexpressionofgermlayermarkers
(BrachyuryT,Sox-1,andAFP)increased.Inaddition,similar
trend was seen with iPS cells. Therefore, the results indicate
that hFF cannot maintain the undiﬀerentiated state of H7
as eﬀectively as MEF. This is consistent with earlier reports,
where mouse feeder cells were more eﬃcient for maintaining
theundiﬀerentiatedstateofhESCcomparedtohumanfeeder
cells [15]. Nevertheless, iPS cell lines tended to be more
variable when compared to hESC lines according to qPCR
results, and this was seen with both of the feeder cell types.
This phenomena might be due to the genomic instability of
iPS cells which has been discussed recently [35–37].
Diﬀerentiated beating cells were troponin T positive,
and most of the beating cells were also ventricular αMHC-
positive. The percentage of ventricular-type cardiomyocytes
varied slightly between cell lines, UTA.00106 producing
79.5%,UTA.0011274.5%,Regea08/01768.5%,H758%,and
Regea 08/017 68.5% of the ventricular type of cells. A similar
results were reported earlier, in a study where the hES2 line
produced 64% ventricular cardiomyocytes and H1 produced
35%, [38]. In the previous report [38], the classiﬁcation was
based on action potential studies, whereas in the present
report we used solely immunocytochemistry results. In our
previous study, immunocytochemistry and action potential
proﬁling provided congruent results [39].
5. Conclusions
The aim of the present study was to evaluate the eﬀect of
MEF and hFF feeder cells on cardiac diﬀerentiation. Four
pluripotent stem cell lines were used: hESC lines Regea
08/017andH7andiPS-celllinesUTA.00106andUTA.00112.
TheMEFfeederssupportedthecardiacdiﬀerentiationbetter,
but a signiﬁcant eﬀect on cardiac diﬀerentiation eﬃciency
was seen with only one cell line used, namely H7. Brachyury
T expression was elevated and a sharper expression peak
at day 3 of diﬀerentiation was observed when cells were
cultured on MEFs than if they were cultured on hFFs. This
aforementioned sharp expression peak is an indicator of
enhanced mesoderm formation and has been reported to be
favourable to cardiac diﬀerentiation [32].
Even though both of the feeder cell types were able to
support the undiﬀerentiated state of the stem cells, increased
expression levels of germ layer markers were observed
especially in the hFF cultures, if the cells had been originally
maintained on MEFs. Therefore, we conclude that the
original feeder layeris important and the cells maintained on
MEFsarenoteasilyadaptedonhFFfeeders.Thechangefrom
hFF to MEF was more successful. The germ layer marker
expression in iPS cell lines was more variable compared to
hESCs in undiﬀerentiated state. However, iPS cells diﬀeren-
tiated into functional cardiomyocytes similarly to hESCs.
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